Knee osteoarthritis: Should your patient opt for hyaluronic acid injection?

Journal of Family Practice

Volumn 55, Issue 8, 2006, Pages 669-675

  Medina, Jennifer M ^a,b   Thomas, Abbey ^a   Denegar, Craig R ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b 146 Recreation Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTZAL; DUROLANE; HYALURONIC ACID; LOCAL ANESTHETIC AGENT; PLACEBO; SODIUM CHLORIDE; SUPLASYN;

ABNORMAL SENSATION; ARTICLE; CINAHL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DATA EXTRACTION; DISABILITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG USE; DURA MATER; HUMAN; HYPOTENSION; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; LEQUESNE INDEX; MEDICAL DECISION MAKING; MEDLINE; META ANALYSIS; MONEY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PALLOR; PATIENT SELECTION; RATING SCALE; SCORING SYSTEM; STOMACH DISCOMFORT; SWEATING; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; WESTERN ONTARIO MCMASTER UNIVERSITIES INDEX;

ADJUVANTS, IMMUNOLOGIC; COST-BENEFIT ANALYSIS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE; PAIN; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES;

EID: 33750703634     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778-799.
2. Sharma L, Kapoor D, Issa S. Epidemiology of osteoarthritis: an update. Curr Opin Rheumatol 2006; 18:147-156.
3. Neyret P, Donell ST, Dejour H. Results of partial meniscectomy related to the state of the anterior cruciate ligament. Review at 20 to 35 years. J Bone Joint Surg Br 1993; 75:36-40.
4. Moskowitz RW, Kelly MA, Lewallen DG. Understanding osteoarthritis of the knee-causes and effects. Am J Orthop 2004; 33:5-9.
5. Walsh DA, Sledge CB, Blanke DR. Biology of the normal joint. In: Kelley WN, Ruddy W, Harris ED Jr, Sledge CB, eds. Textbook of Rheumatology. Vol 1. 5th ed. Philadelphia, PA: W.B. Saunders Company; 1997:1-26.
6. Leardini G, Mattara L, Franceschini M, Perbellini A. Intraarticular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and -methyl prednisolone acetate. Clin Exp Rheumatol 1991; 9:375-381.
7. Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2002; 41:1240-1248.
8. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993; 1:97-103.
9. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999; 38:602-607.
10. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris) 1974; 22:731-736.
11. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 1982; 20:501-507.
12. Bellamy N, Buchanan W, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1999; 15:1833-1840.
13. Faucher M, Poiraudeau S, Lefevre-Colau MM, Rannou F, Fermanian F, Revel M. Algo-functional assessment of knee osteoarthritis: comparison of the test-retest reliability and construct validity of the WOMAC and Lequesne indexes. Osteoarth Cartil 2002; 10:602-610.
14. PEDro Scale. Physiotherapy Evidence Database Web site. Available at: www.pedro.fhs.usyd.edu.au/scale_item.html. Accessed on February 10, 2005.
15. Wang C, Lin J, Chang C, Lin Y, Hou S. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. J Bone Joint Surg 2004; 86A:538-545.
16. Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004; 31:775-782.
17. Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004; 12:642-649.
18. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning on osteoarthritis of the knee. Arch Intern Med 2002; 162:292-298.
19. Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomized controlled study in symptomatic knee osteoarthritis. Ann Rhem Dis 2004; 63:1611-1617.
20. Modawal A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005; 54:758-677.
21. Kahan A, Lleu P, Salin L. Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003; 70:276-281.
22. Brandt KD, Block JA, Michalski JR Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clin Orthop 2001; 385:130-143.